Classification ![]() |
|
| Compound class | Endogenous peptide in human, mouse or rat |
| Approved drug? | Yes (source: FDA (1989)) |
Gene/Precursor ![]() |
||||||||||
|
Synonyms ![]() |
| IFN-alpha-2 |
| interferon alpha-2 |
| Roferon A® |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 624 |
| Other databases | |
| Ensembl Gene | ENSG00000188379 (Hs) |
| UniProtKB | P01563 (Hs) |
| Wikipedia | IFNA2 |
| Comments |
| IFN-α2 is a type I IFN. The sequence of the recombinant peptide used clinically and known as interferon alfa-2a, is identical to that of human IFN-α2. Interferon alfa-2a has anti-viral, immunomodulatory and antineoplastic actions. It is on the World Health Organization's List of Essential Medicines (link to 2015 list). |